CMS Dashes Industry Hopes For MCIT Rule Any Time Soon
The US Medicare agency has proposed to withdraw a rule that would give temporary automatic coverage to breakthrough devices, stating the rule doesn’t meet its evidence threshold and could put patients at risk.
You may also be interested in...
A CMS official announced that the agency is working on a proposal to replace breakthrough device coverage scheme MCIT that will balance ensuring product safety with narrowing the “valley of death.”
In a letter to CMS Administrator Chiquita Brooks-LaSure, the industry association argues that repealing MCIT would deny many Americans access to “transformational” medical technologies.
A panel of experts in the health care and medical device industries discussed the fate of the Medicare Coverage for Innovative Technology (MCIT) rule during AdvaMed’s annual Medtech Conference.